European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
Authors
Keywords
-
Journal
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
Volume 36, Issue 9, Pages 1409-1431
Publisher
Wiley
Online
2022-08-18
DOI
10.1111/jdv.18345
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics
- (2021) J.P. Thyssen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Nemolizumab is Associated with a Rapid Improvement in Atopic Dermatitis Signs and Symptoms: Subpopulation (EASI ≥16) Analysis of Randomized Phase 2B Study
- (2021) J.I. Silverberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Inborn Error of Immunity or Atopic Dermatitis: When to be Concerned and How to Investigate
- (2021) Pia-Charlotte Stadler et al. Journal of Allergy and Clinical Immunology-In Practice
- Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
- (2021) Thomas Bieber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term Efficacy of Baricitinib in Adults With Moderate to Severe Atopic Dermatitis Who Were Treatment Responders or Partial Responders
- (2021) Jonathan I. Silverberg et al. JAMA Dermatology
- Targeting immunoglobulin E in atopic dermatitis: A review of the existing evidence
- (2021) Andreas Wollenberg et al. World Allergy Organization Journal
- Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program
- (2021) Eric L. Simpson et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Upadacitinib plus topical corticosteroids in atopic dermatitis: week-52 AD Up study results
- (2021) Jonathan I. Silverberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) Kristian Reich et al. LANCET
- Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
- (2021) Emma Guttman-Yassky et al. LANCET
- Efficacy and Safety of Abrocitinib in Combination With Topical Therapy in Adolescents With Moderate-to-Severe Atopic Dermatitis
- (2021) Lawrence F. Eichenfield et al. JAMA Dermatology
- Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis
- (2021) Andrew Blauvelt et al. JAMA Dermatology
- Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis
- (2021) Jonathan I. Silverberg et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Safety of baricitinib for the treatment of rheumatoid arthritis over a median of 4.6 and up to 9.3 years of treatment: final results from long-term extension study and integrated database
- (2021) Peter C Taylor et al. ANNALS OF THE RHEUMATIC DISEASES
- Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis
- (2020) Emma Guttman-Yassky et al. JAMA Dermatology
- How does methotrexate work?
- (2020) Adel M. Alqarni et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis
- (2020) Andreas Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Systemic Immunomodulatory Treatments for Patients With Atopic Dermatitis
- (2020) Aaron M. Drucker et al. JAMA Dermatology
- Dupilumab Provides Favorable Safety and Sustained Efficacy for up to 3 Years in an Open-Label Study of Adults with Moderate-to-Severe Atopic Dermatitis
- (2020) Lisa A. Beck et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Drug survival of dupilumab compared to cyclosporin in moderate‐to‐severe atopic dermatitis patients
- (2020) Giacomo Dal Bello et al. Dermatologic Therapy
- Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- (2020) Eric L Simpson et al. LANCET
- Trial of Nemolizumab and Topical Agents for Atopic Dermatitis with Pruritus
- (2020) Kenji Kabashima et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial
- (2020) J.I. Silverberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Tralokinumab for moderate‐to‐severe atopic dermatitis: results from two 52‐week, randomized, double‐blind, multicentre, placebo‐controlled phase III trials (ECZTRA 1 and ECZTRA 2)
- (2020) A. Wollenberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Pooled safety analysis of baricitinib in adult patients with atopic dermatitis from 8 randomized clinical trials
- (2020) T. Bieber et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis
- (2020) Kristian Reich et al. JAMA Dermatology
- ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
- (2020) A. Wollenberg et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Conjunctivitis in dupilumab clinical trials
- (2019) B. Akinlade et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response
- (2019) Roy M Fleischmann et al. ANNALS OF THE RHEUMATIC DISEASES
- European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period
- (2019) C. Vestergaard et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Laboratory safety of dupilumab in moderate‐to‐severe atopic dermatitis: results from three phase III trials ( LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS )
- (2019) A. Wollenberg et al. BRITISH JOURNAL OF DERMATOLOGY
- Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus
- (2019) Jonathan I. Silverberg et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis
- (2019) Kevin Phan et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Upadacitinib in Adults With Moderate-to-Severe Atopic Dermatitis: 16-Week Results From a Randomized, Placebo-Controlled Trial
- (2019) Emma Guttman-Yassky et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment Effect of Omalizumab on Severe Pediatric Atopic Dermatitis
- (2019) Susan Chan et al. JAMA Pediatrics
- Safe and effective use of alitretinoin in children with recalcitrant hand eczema and other dermatoses – a retrospective analysis
- (2019) I. Luchsinger et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- (2019) Farzan Solimani et al. Frontiers in Immunology
- Methotrexate and azathioprine for severe atopic dermatitis: a 5-year follow-up study of a randomized controlled trial
- (2018) L.A.A. Gerbens et al. BRITISH JOURNAL OF DERMATOLOGY
- Methotrexate in the Treatment of Moderate to Severe Atopic Dermatitis: A Retrospective Study
- (2018) Nidhi Shah et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis
- (2018) David Dias-Polak et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Efficacy and safety of lebrikizumab (an anti-IL-13 monoclonal antibody) in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical corticosteroids: A randomized, placebo-controlled phase II trial (TREBLE)
- (2018) Eric L. Simpson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Conjunctivitis occurring in atopic dermatitis patients treated with dupilumab-clinical characteristics and treatment
- (2018) Andreas Wollenberg et al. Journal of Allergy and Clinical Immunology-In Practice
- Methotrexate Versus Cyclosporine in Adults with Moderate-to-Severe Atopic Dermatitis: A Phase III Randomized Noninferiority Trial
- (2018) Catherine Goujon et al. Journal of Allergy and Clinical Immunology-In Practice
- The use of methotrexate for treating childhood atopic dermatitis: a multicenter retrospective study
- (2018) Yossi Taieb et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Relative efficacy of systemic treatments for atopic dermatitis
- (2018) Edward W. Seger et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Structural Characterisation Reveals Mechanism of IL-13-Neutralising Monoclonal Antibody Tralokinumab as Inhibition of Binding to IL-13Rα1 and IL-13Rα2
- (2017) B. Popovic et al. JOURNAL OF MOLECULAR BIOLOGY
- Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial
- (2017) Andrew Blauvelt et al. LANCET
- Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis
- (2017) Thomas Ruzicka et al. NEW ENGLAND JOURNAL OF MEDICINE
- Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment
- (2017) Roy Fleischmann et al. Arthritis & Rheumatology
- Efficacy of omalizumab in patients with atopic dermatitis: A systematic review and meta-analysis
- (2016) Hsiao-Han Wang et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
- (2016) Eric L. Simpson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum Creatinine Levels During and After Long-term Treatment with Cyclosporine A in Patients with Severe Atopic Dermatitis
- (2015) J Schaft et al. ACTA DERMATO-VENEREOLOGICA
- Outcome of treatment with azathioprine in severe atopic dermatitis: a 5-year retrospective study of adult outpatients
- (2015) S.F. Thomsen et al. BRITISH JOURNAL OF DERMATOLOGY
- The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling
- (2015) Wataru Amano et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Ten years experience with oral immunosuppressive treatment in adult patients with atopic dermatitis in two academic centres
- (2015) F.M. Garritsen et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Methotrexate for treatment of atopic dermatitis in children and adolescents
- (2014) Maneka Deo et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials
- (2014) Jochen Schmitt et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis
- (2014) Lisa A. Beck et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systemic methotrexate therapy for psoriasis: past, present and future
- (2013) S. Dogra et al. CLINICAL AND EXPERIMENTAL DERMATOLOGY
- Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: A systematic review
- (2013) Evelien Roekevisch et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Omalizumab in chronic urticaria
- (2012) Martin Metz et al. Current Opinion in Allergy and Clinical Immunology
- Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt
- (2012) Mohamed A. El-Khalawany et al. EUROPEAN JOURNAL OF PEDIATRICS
- British Association of Dermatologists’ guidelines for the safe and effective prescribing of azathioprine 2011
- (2011) S.J. Meggitt et al. BRITISH JOURNAL OF DERMATOLOGY
- A randomized trial of methotrexate versus azathioprine for severe atopic eczema
- (2011) Mandy Elvira Schram et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment of atopic eczema with oral alitretinoin
- (2009) M. Grahovac et al. BRITISH JOURNAL OF DERMATOLOGY
- Safety and tolerability of omalizumab
- (2009) J. Corren et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults
- (2009) A Lyakhovitsky et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial
- (2008) T. Ruzicka et al. BRITISH JOURNAL OF DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started